Hepatitis B Virus: From Diagnosis to Treatment

Pol J Microbiol. 2020 Dec;69(4):391-399. doi: 10.33073/pjm-2020-044. Epub 2020 Dec 27.

Abstract

Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe liver failure, and death. The infection is most widely transmitted from the infected mother to a child, with infected blood and body fluids. Pregnant women, adolescents, and all adults at high risk of chronic infection are recommended to be screened for hepatitis B infection. The initial analysis includes serological tests that allow differentiation of acute and chronic hepatitis. Molecular assays performed provide detection and quantification of viral DNA, genotyping, drug resistance, and precore/core mutation analysis to confirm infection and monitor disease progression in chronic hepatitis B patients. All patients with chronic hepatitis B should be treated with antiviral medications and regularly monitored for efficient treatment. The current treatment is based on nucleos(t)ide analogs and pegylated interferons that save lives by decreasing liver cancer death, liver transplant, slow or reverse the progression of liver disease as well as the virus infectivity.

Keywords: antiviral treatment; hepatitis B virus (HBV); nucleic acid testing; serology.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • DNA, Viral / analysis
  • Hepatitis B / diagnosis*
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Hepatitis B Antibodies / blood
  • Hepatitis B Antigens / blood
  • Hepatitis B virus* / classification
  • Hepatitis B virus* / genetics
  • Hepatitis B virus* / isolation & purification
  • Hepatitis B virus* / physiology
  • Hepatitis B, Chronic / diagnosis
  • Hepatitis B, Chronic / drug therapy
  • Hepatitis B, Chronic / virology
  • Humans
  • Molecular Diagnostic Techniques
  • Serologic Tests
  • Viral Load

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B Antibodies
  • Hepatitis B Antigens